DRAXIS and University of Toronto Drop Anipryl Lawsuits
They said the settlement involved no payments. The animal health subsidiary of DRAXIS will continue to license the animal health applications of l-deprenyl technologies owned by UTIF.
On July 28, 2000, the University of Toronto announced that negotiations with drug manufacturer Draxis had ended and that it had filed a $100 million lawsuit claiming that Anipryl belongs the...
To view the full article, register now.